A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
Authors
Keywords
-
Journal
Viruses-Basel
Volume 11, Issue 9, Pages 799
Publisher
MDPI AG
Online
2019-08-29
DOI
10.3390/v11090799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice
- (2018) Bo Li et al. MICROBIAL PATHOGENESIS
- DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
- (2017) Hang Chi et al. VACCINE
- Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
- (2017) Sawsan S. Al-amri et al. Scientific Reports
- Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
- (2017) Joel N. Maslow Human Vaccines & Immunotherapeutics
- Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels
- (2017) Ren-qiang LIU et al. Journal of Integrative Agriculture
- Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus
- (2017) Jie Zhou et al. Science Advances
- One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
- (2016) Christoph Wirblich et al. JOURNAL OF VIROLOGY
- Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications
- (2016) C. Michon et al. Microbial Cell Factories
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis
- (2016) Peng-cheng Li et al. VACCINE
- MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
- (2016) Chong Wang et al. Oncotarget
- A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
- (2015) Yan Li et al. CELL RESEARCH
- Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
- (2015) Xiaojuan Guo et al. IMMUNOLOGY
- Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice
- (2015) Shannon J Heine et al. IMMUNOLOGY AND CELL BIOLOGY
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
- (2015) Anna H. Malczyk et al. JOURNAL OF VIROLOGY
- Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
- (2015) Asisa Volz et al. JOURNAL OF VIROLOGY
- MERS in South Korea and China: a potential outbreak threat?
- (2015) Shuo Su et al. LANCET
- An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
- (2015) B. L. Haagmans et al. SCIENCE
- A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
- (2015) Karuppiah Muthumani et al. Science Translational Medicine
- Receptor-binding domain-based subunit vaccines against MERS-CoV
- (2015) Naru Zhang et al. VIRUS RESEARCH
- Immune responses to vaccines involving a combined antigen–nanoparticle mixture and nanoparticle-encapsulated antigen formulation
- (2014) Weifeng Zhang et al. BIOMATERIALS
- Current advancements and potential strategies in the development of MERS-CoV vaccines
- (2014) Naru Zhang et al. Expert Review of Vaccines
- Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
- (2014) Jiaming Lan et al. PLoS One
- Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
- (2014) Cuiqing Ma et al. VACCINE
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- The emergence of the Middle East Respiratory Syndrome coronavirus
- (2014) Shauna Milne-Price et al. Pathogens and Disease
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
- (2013) H. Mou et al. JOURNAL OF VIROLOGY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
- (2013) Abdullah Assiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles
- (2013) Alan Rigter et al. PLoS One
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Fusion protein linkers: Property, design and functionality
- (2012) Xiaoying Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice
- (2012) Krystelle Nganou-Makamdop et al. MALARIA JOURNAL
- Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection
- (2009) K Ramirez et al. Mucosal Immunology
- LysM, a widely distributed protein motif for binding to (peptido)glycans
- (2008) Girbe Buist et al. MOLECULAR MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now